mHealth Technology and CVD Risk Reduction.

Autor: Cajita MI; College of Nursing, University of Illinois at Chicago, 845 S. Damen Ave., Room 756, Chicago, IL, USA. mcajit2@uic.edu., Zheng Y; Rory Meyers College of Nursing, New York University, New York, NY, USA., Kariuki JK; School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA., Vuckovic KM; College of Nursing, University of Illinois at Chicago, 845 S. Damen Ave., Room 756, Chicago, IL, USA., Burke LE; School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Jazyk: angličtina
Zdroj: Current atherosclerosis reports [Curr Atheroscler Rep] 2021 May 13; Vol. 23 (7), pp. 36. Date of Electronic Publication: 2021 May 13.
DOI: 10.1007/s11883-021-00927-2
Abstrakt: Purpose of Review: To review existing mHealth-based interventions and examine their efficacy in reducing cardiovascular disease (CVD) risk factors.
Recent Findings: A total of 50 articles are included in this review. The majority of the mHealth interventions targeted a specific CVD risk factor, while 4 addressed 2 or more CVD risk factors. Of the 9 mHealth-supported weight loss intervention trials, 4 resulted in significant weight loss. Four out of 7 RCTs targeting improvement in physical activity reported significant improvement, while 4 of the 8 mHealth-supported smoking cessation intervention trials resulted in smoking abstinence. Of the 10 mHealth-based diabetes intervention trials, 5 reported significant reductions in HbA1c; however, only 3 out of the 9 antihypertension interventions resulted in significant reductions in blood pressure. There is a growing body of literature focused on mHealth interventions that address CVD risk factors. Despite the immense potential of mHealth interventions, evidence of their efficacy in mitigating cardiovascular risk is heterogeneous.
Databáze: MEDLINE